Table 1.
Groups compared | MST (days) and survival rate (%) | P value |
---|---|---|
DL vs. MMB3.19 | 27, 12% vs. 21, 0% | < 0.01 |
GM-MMB3.19 post-BMT + DL vs. DL | 26.5, 14.3% vs. 27, 12% | NS (0.8) |
GM-MMB3.19 pre-BMT +DL vs. DL | 52% vs. 27, 12% | < 0.01 |
GM-MMB3.19 pre-BMT +DL vs. GM-MMB3.19 post-BMT | 52% vs. 26.5, 14.3% | < 0.01 |
non-GM-MMB3.19 pre-BMT + DL vs. DL | 37.5, 25% vs. 27, 12% | = 0.03 |
GM-MMB3.19 pre-BMT + DL vs. non-GM-MMB3.19 + DL | 52% vs. 37.5, 25% | = 0.03 (stratified: ≥ 30 days)* |
Cox-proportional hazards test p < 0.01
Groups were compared using non-parametric Log-Rank test